Johnson & Johnson (JNJ) Management Presents at BofA Securities Health Care Conference (Transcript)

Johnson & Johnson (NYSE:JNJ) BofA Securities Health Care Conference Transcript May 14, 2024 4:40 PM ET Executives John Reed - Executive Vice President, Innovative Medicine, R&D Analysts Geoff Meacham - Bank of America Charlie Yang - Bank of America Geoff Meacham The afternoon sessions of the first day of the BofA Healthcare Conference. My name is Geoff Meacham, I’m the Senior Biopharma Analyst here at BofA. And Charlie Yang from my team is on stage as well. So we’re thrilled today to have Johnson & Johnson ...